Amgen Breakfast Symposium: From evidence to impact: Improving LDL-C management through implementation science
Friday, August 15, 2025 |
7:15 AM - 8:15 AM |
Plaza 4 |
Details
Optimising LDL-C management from a systems and processes perspective - exploring how implementation science and clinician behaviour can help bridge the gap between guidelines and real-world practice to drive improved patient outcomes.
Learning Objectives:
• Describing the evidence-practice gap in LDL-C goal attainment.
• Identifying barriers to implementing lipid-lowering guidelines.
• Applying implementation science strategies to improve LDL-C management and achieve target levels
• Learning from global and local experiences.
Speaker
Dr Andrew Black
Cardiologist
Royal Hobart Hospital
Welcome and acknowledgment of country
7:15 AM - 7:20 AMBiography
Andrew is a Senior Staff Specialist Cardiologist at the Royal Hobart Hospital, Tasmania. He completed interventional cardiology training at the Libin Cardiovascular Institute in Alberta, Canada, and has a strong interest in health systems research. His work focuses on optimising ACS and STEMI systems of care, embedding preventive cardiology within existing pathways, and improving the detection and management of familial hypercholesterolaemia.
Prof Peter Toth
Director of Research Service Facility - Cellular Imaging
University of Illinois at Chicago
Improving LDL-C management through science: A US perspective
7:20 AM - 7:40 AMBiography
Peter P. Toth, MD, PhD is Director of Preventive Cardiology at the CGH Medical Center in Sterling, Illinois, USA. He is Professor of Clinical Family and Community Medicine at the University of Illinois School of Medicine and Adjunct Professor of Medicine at the Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine. Dr. Toth is a past president of the National Lipid Association, the American Board of Clinical Lipidology, and the American Society for Preventive Cardiology. He is the immediate past chair of the American Heart Association’s Council on Lipids, Lipoproteins, and Thrombosis and is a member of the American College of Cardiology’s Board of Councilors. Dr. Toth has authored and co-authored over 500 publications in medical and scientific journals and textbooks. He is Series Editor of Springer’s textbook collection in Contemporary Cardiology. He has edited and written 23 textbooks on various aspects of cardiovascular medicine. He has lectured on many topics in cardiovascular medicine throughout the world.
Dr Andrew Black
Cardiologist
Royal Hobart Hospital
Local Australian perspective and landscape
7:40 AM - 8:10 AMBiography
Andrew is a Senior Staff Specialist Cardiologist at the Royal Hobart Hospital, Tasmania. He completed interventional cardiology training at the Libin Cardiovascular Institute in Alberta, Canada, and has a strong interest in health systems research. His work focuses on optimising ACS and STEMI systems of care, embedding preventive cardiology within existing pathways, and improving the detection and management of familial hypercholesterolaemia.
All speakers
Discussion/Q&A
8:00 AM - 8:10 AMBiography
Dr Andrew Black
Cardiologist
Royal Hobart Hospital
Summary and close
8:10 AM - 8:15 AMBiography
Andrew is a Senior Staff Specialist Cardiologist at the Royal Hobart Hospital, Tasmania. He completed interventional cardiology training at the Libin Cardiovascular Institute in Alberta, Canada, and has a strong interest in health systems research. His work focuses on optimising ACS and STEMI systems of care, embedding preventive cardiology within existing pathways, and improving the detection and management of familial hypercholesterolaemia.
Dr Andrew Black
Cardiologist
Royal Hobart Hospital
Chairperson
Biography
Andrew is a Senior Staff Specialist Cardiologist at the Royal Hobart Hospital, Tasmania. He completed interventional cardiology training at the Libin Cardiovascular Institute in Alberta, Canada, and has a strong interest in health systems research. His work focuses on optimising ACS and STEMI systems of care, embedding preventive cardiology within existing pathways, and improving the detection and management of familial hypercholesterolaemia.
